Next-Generation Sequencing for Lymphoid Genomic Profiling

The need for more comprehensive lymphoid testing is growing

As the list of known mutations and relevant genes for lymphoid disorders increases, characterizing these samples becomes more complicated and time-consuming. To get meaningful genetic insights, you need a rapid and efficient approach for evaluating all key mutations upfront. Next-generation sequencing (NGS) can streamline the path from sample to result by providing a comprehensive molecular profile with speed and simplicity.


On Demand Webinar: Utility of NGS in lymphoid malignancies and Ion AmpliSeq Liverpool Lymphoid Network Panel experience

NGS has become a key component of molecular testing in both myeloid and lymphoproliferative neoplasms. It can facilitate improvements in classification, prognostication and identification of therapeutic targets. In this presentation, hear our expert share the utility of faster molecular results in lymphoid genomic profiling and their experience with the Genexus System and the Ion AmpliSeq Liverpool Lymphoid Network Panel.

Dr. Michael Krigstein

Consultant Haematologist MBBS(Hons) FRACP FRCPA MCncrSc

SydPath, St Vincent’s Hospital

Sydney, Australia

On Demand Webinar: Implementing NGS for the study of lymphoid malignancies

In this on-demand webinar, Dr. Gerard Frigola discusses his experience with the new Ion AmpliSeq Liverpool Lymphoid Network Panel and shares compelling analytical data from his lab to demonstrate the impact of NGS for lymphoid
malignancy research.

Gerard Frigola, MD

Hematopathologist

Hospital Clinic, IDIBAPS

University of Barcelona


Ion AmpliSeq Liverpool Lymphoid Network Panel benefits

The Ion AmpliSeq Liverpool Lymphoid Network Panel is a community panel designed by leading clinical researchers for more comprehensive lymphoid genomic profiling.

 

Rapid Automated Comprehensive Verified performance Community network
Go from specimen to result in as little as one day Process samples with minimal hands-on time, available on both GeneStudio & Genexus Simultaneously profile 60 key DNA mutations relevant for a broad range of lymphoid disorders Reliably detect variants using a panel designed and tested by community users with real-world clinical research samples Access a community network of labs and contribute to future iterations of the panel design

Profile 60 key DNA mutations with one test

Panel content has been curated to cover relevant targets for T-cell and B-cell lymphomas, leukemias and other lymphoproliferative disorders. It is compatible with all common sample types, including blood, bone marrow and formalin-fixed paraffin embedded (FFPE) tissue.

 

Ion AmpliSeq panel design includes:

  • Essential exons and full coding sequence coverage of key genes
  • 3’ UTR coverage of NOTCH1
  • Non-coding exon 1 of BCL6  and partial intron 1

 

Essential exons (36) Full coding sequence (24)
BCL6 IRF4 ARID1A PAX5
BIRC3 KRAS ATM PIM1
BRAF MAP2K1 B2M PRDM1
BTK MYD88 BCL2 PTEN
CARD11 NOTCH1 CDKN2A SAMHD1
CCND1 NOTCH2 CREBBP SGK1
CCND3 NRAS DIS3 SOCS1
CD79B PLCG2 GNA13 TENT5C
CXCR4 POT1 ID3 TET2
DNMT3A RHOA KMT2D TNFAIP3
EP300 RPS15 MEF2B TP53
ETV6 SF3B1 MYC  
EZH2 SMARCA4 NFKBIE  
FAS STAT3    
FBXW7 STAT5B    
FOXO1 STAT6    
HRAS TNFRSF14    
IDH2 XPO1    

 

Oncomine Lymphoma Panel

The Oncomine Lymphoma Panel contains 25 key genes associated with all major B-cell lymphomas, including DLBCL, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphomas. This panel provides robust performance with as little as 10 ng of input and comes with an end-to-end, clinical research-grade workflow including straightforward, customizable report that summarizes the findings. It is available for the Ion Chef and Ion GeneStudio S5 systems. Customize the assay to suit your needs by selecting from a library of primer designs to add additional gene targets.

 

 

Lymphoma
ARID1A BRAF CDKN2A HIST1H1E MYD88 TNFAIP3
ATM BTK CREBBP KMT2D PIM1 TNFRSF14
B2M CARD11 EZH2 MTOR SOCS1 TP53
BCL2 CD79B GNA13 MYC SF3B1 XPO1
BCL6          

NGS systems

The Oncomine Comprehensive Assay v3 is available on the Genexus System and additionally available for use on the Ion GeneStudio S5 System with manual or automated library preparations.

Genexus System

The Ion Torrent Genexus System automates sample and library preparation, sequencing, analysis, and reporting.

Ion GeneStudio S5 System

The Ion GeneStudio S5 systems are designed to enable a broad range of targeted ngs applications with speed and scalability. 


Ordering information


Ready to speak to a Thermo Fisher representative?

We will be happy to answer your questions and provide a demo of our NGS solutions.

For Research Use Only. Not for use in diagnostic procedures.